Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Chemosensitizing effect of peptides from lentinus squarrosulus on cisplatin-induced apoptosis in human lung cancer cells

View through CrossRef
Cisplatin, platinum-based chemotherapy, is one of the standard chemotherapies for the treatment of lung cancer. However, its usefulness is limited due to the adverse effects and susceptibility to chemoresistance which lead to therapeutic failure. Nowadays, natural chemosensitizers, which can enhance the efficacy and decrease the effective dose of chemo-drugs, have been found to be interested in novel therapeutic. Recently, the anticancer activity of peptides extracted from Lentinus squarrosulus Mont. in human lung cancer cells has been reported. The novel potential of L. squarrosulus peptides as a chemotherapeutic adjuvant to increase cisplatin-induced apoptosis was uncovered in this study. Crude peptides extracted from fresh fruiting bodies of L. squarrosulus Mont. were further purifies by fast protein liquid chromatography on HiTrap, DEAE FF column. The bound peptides were eluted with stepwise increase salt concentration (0.1, 0.2, 0.3, 0.4 and 0.5 M NaCl) in phosphate buffer (pH 7.4). The peptide fraction with highest purity (eluted with 0.4 M NaCl in phosphate buffer, pH 7.4) was used for further experiment. The maximum non-toxic concentration of 0.4 M NaCl eluted peptides was found to be 5 µg/mL in lung cancer H460 cells, dermal papilla (DP) and proximal renal (HK-2) cells. Flow cytometry, cell viability and co-staining assays confirmed that pre-treatment with peptide increased cisplatin-induced apoptosis in H460 cells in comparison to only cisplatin treated group. Western blot analysis result showed that peptide activated p53, a tumor suppressor and pro-apoptosis BAX protein as well as decreased anti-apoptotic protein, Mcl-1 and Bcl-2. Moreover, treatment of H460 cells with peptide down-regulated the level of integrins (α5, αV, β1, β3, β5) and down-stream survival molecules (pFAK/FAK, pSrc/Src, pAkt/Akt) with time-dependent manner. In addition, peptide selectively sensitized cisplatin toxicity on lung cancer H23, H292 and A549 cells without affecting DPs and HK-2 cells. However, 0.4 M NaCl eluted peptide pretreatment did not increase the viability of 25 uM cisplatin-treated human renal cells. Interestingly, peptides from 0.5 M NaCl fraction could preserve the viability of 25 uM cisplatin-treated HK-2 cells with time-dependent manner. Augmentation of the anti-apoptosis proteins, Mcl-1 and Bcl-2, as well as key survival signaling proteins, Akt and its active form pAkt, were shown after 24 h treatment with 5 µg/mL of this peptide fraction on HK-2 cells. The novel findings herein encourage the development of peptides from Lentinus squarrosulus Mont. as potential chemotherapeutic adjuvant peptides.
Office of Academic Resources, Chulalongkorn University
Title: Chemosensitizing effect of peptides from lentinus squarrosulus on cisplatin-induced apoptosis in human lung cancer cells
Description:
Cisplatin, platinum-based chemotherapy, is one of the standard chemotherapies for the treatment of lung cancer.
However, its usefulness is limited due to the adverse effects and susceptibility to chemoresistance which lead to therapeutic failure.
Nowadays, natural chemosensitizers, which can enhance the efficacy and decrease the effective dose of chemo-drugs, have been found to be interested in novel therapeutic.
Recently, the anticancer activity of peptides extracted from Lentinus squarrosulus Mont.
in human lung cancer cells has been reported.
The novel potential of L.
squarrosulus peptides as a chemotherapeutic adjuvant to increase cisplatin-induced apoptosis was uncovered in this study.
Crude peptides extracted from fresh fruiting bodies of L.
squarrosulus Mont.
were further purifies by fast protein liquid chromatography on HiTrap, DEAE FF column.
The bound peptides were eluted with stepwise increase salt concentration (0.
1, 0.
2, 0.
3, 0.
4 and 0.
5 M NaCl) in phosphate buffer (pH 7.
4).
The peptide fraction with highest purity (eluted with 0.
4 M NaCl in phosphate buffer, pH 7.
4) was used for further experiment.
The maximum non-toxic concentration of 0.
4 M NaCl eluted peptides was found to be 5 µg/mL in lung cancer H460 cells, dermal papilla (DP) and proximal renal (HK-2) cells.
Flow cytometry, cell viability and co-staining assays confirmed that pre-treatment with peptide increased cisplatin-induced apoptosis in H460 cells in comparison to only cisplatin treated group.
Western blot analysis result showed that peptide activated p53, a tumor suppressor and pro-apoptosis BAX protein as well as decreased anti-apoptotic protein, Mcl-1 and Bcl-2.
Moreover, treatment of H460 cells with peptide down-regulated the level of integrins (α5, αV, β1, β3, β5) and down-stream survival molecules (pFAK/FAK, pSrc/Src, pAkt/Akt) with time-dependent manner.
In addition, peptide selectively sensitized cisplatin toxicity on lung cancer H23, H292 and A549 cells without affecting DPs and HK-2 cells.
However, 0.
4 M NaCl eluted peptide pretreatment did not increase the viability of 25 uM cisplatin-treated human renal cells.
Interestingly, peptides from 0.
5 M NaCl fraction could preserve the viability of 25 uM cisplatin-treated HK-2 cells with time-dependent manner.
Augmentation of the anti-apoptosis proteins, Mcl-1 and Bcl-2, as well as key survival signaling proteins, Akt and its active form pAkt, were shown after 24 h treatment with 5 µg/mL of this peptide fraction on HK-2 cells.
The novel findings herein encourage the development of peptides from Lentinus squarrosulus Mont.
as potential chemotherapeutic adjuvant peptides.

Related Results

Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract Cisplatin is the most commonly employed chemotherapeutic drug for ovarian cancer treatment. However, most ovarian cancer patients experience recurrent cispl...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
Apoptosis inducing effect of peptide/protein extracts from lentinus squarrosulus mont. In human h460 lung cancer cells
Apoptosis inducing effect of peptide/protein extracts from lentinus squarrosulus mont. In human h460 lung cancer cells
In searching for the novel compounds with improving efficacy and safety profile for the treatment of lung cancer, anti-cancer activity and underlying mechanism of proteins extracte...
Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy
Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy
Abstract INTRODUCTION: Acute myeloid leukemia (AML) represents a genetically heterogeneous hematological malignancy and is among top 10 common cancers in China. Thou...
Cytoplasmic APE1 promotes lung cancer aggressiveness and cisplatin resistance via the COX-2/Akt/β-catenin pathway 
Cytoplasmic APE1 promotes lung cancer aggressiveness and cisplatin resistance via the COX-2/Akt/β-catenin pathway 
Abstract Background Cisplatin is commonly used in lung cancer therapy, but cisplatin resistance in lung cancer cells remains an unsolved problem. Here, we report that cyto...
Abstract 232: Cancer stem cells and cisplatin.
Abstract 232: Cancer stem cells and cisplatin.
Abstract Introduction: Cisplatin is an important chemotherapeutic agent, which has resulted in higher overall response rates when combined with 5-FU o...
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract Cisplatin has been mainly used for lung-cancer. However, cisplatin has many side effects, so the usage of cisplatin has a limitation. Recently, autophagy ha...

Back to Top